OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Gnome Diagnostics, LLC.

1 Projects | 1 Researchers | $181,750 Invested

2016

Gnome Diagnostics, LLC.

Gerard Nuovo, MD

The utility of cFLIP and MCL 1 and their regulatory microRNAs as novel biomarkers of Alzheimer's disease

  • Funding Amount: $181,750
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Other
  • Status: Closed